Results 91 to 100 of about 16,400 (167)

IGLV3-21^R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL. [PDF]

Hemasphere
Yosifov DY, Robrecht S, Giza A, Maity PC, Riecke A, Schneider C, Jebaraj BMC, Dheenadayalan RP, Jumaa H, Young M, Kumar M, Müller L, Vehling-Kaiser U, Eckart M, Freier W, Schöttker B, Gaska T, Reiser M, Fink AM, Fischer K, Eichhorst B, Hallek M, Langerbeins P, Tausch E, Stilgenbauer S.   +24 more
europepmc   +1 more source

When pseudo-Richter transformation hits the spleen: a case report and literature review. [PDF]

J Hematop
Onieva R, Rama L, Blázquez C, Astorga R, Escudero L, Ramila ME, Ramos MC, Papaleo N.   +7 more
europepmc   +1 more source

A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia. [PDF]

Blood Cancer J
Parrondo RD, Ailawadhi S, Knopf BR, Zimmerman A, Kasik CJ, Chapin D, Heslop K, Roy V, Paulus A, Chanan-Khan AA.   +9 more
europepmc   +1 more source

Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies. [PDF]

Int J Mol Sci
Meza K, Barrientos Risso C, Shah A, Romagnoli C, Sandoval J, Brauchle Y, Lyubimova A, Santos L, Goya Balaguer E, Barrientos J.   +9 more
europepmc   +1 more source

Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib. [PDF]

Eur Heart J Case Rep
Dirir O, Parker WAE, Haley HA, Gunn JP, Storey RF.   +4 more
europepmc   +1 more source

Visualization of a Bruton's Tyrosine Kinase Inhibitor Using Fluorescence and Raman Microscopy. [PDF]

Anal Chem
Merchant AS, Tipping WJ, Graham D, Faulds K.   +3 more
europepmc   +1 more source

Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia. [PDF]

Blood
Sun H, Sklavenitis-Pistofidis R, Liu S, Liu X, Tsakmaklis N, Hatcher JM, Guerrera ML, Kofides A, Ramirez-Gamero A, Peachey AL, Li S, Keskin DB, Chea V, Kim N, Lyu H, Lu W, Livak KJ, Meid K, Guijosa A, Flynn CA, Pizzarella D, Patterson CJ, Hao M, Yi S, Yuan W, Branagan AR, Wu CJ, Ghobrial IM, Qiu L, Sarosiek SR, Castillo JJ, Hunter ZR, Treon SP.   +32 more
europepmc   +1 more source

Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. [PDF]

Leukemia
Álvarez-Corrales E, Moreno-Palomares R, Gómez-Escolar C, Martínez M, Moral-Pérez U, Laguna-Herrero M, Fuertes T, Estrada BS, Mur S, de Bonis A, Leiva M, Martínez-Martín N, Somoza Á, Ramiro AR, de Yébenes VG.   +14 more
europepmc   +1 more source

The Immunologic Paradox of BTK Inhibitors in Chronic Lymphocytic Leukemia: Selectivity, Hypogammaglobulinemia, and Infection Risk. [PDF]

Cancers (Basel)
Andreescu M, Tudorache SI, Moldovan CA, Moldovan AD, Cochior D, Popov V, Andreescu B, Ionescu D, Padurariu-Covit MD.   +8 more
europepmc   +1 more source

Prognostic value of <i>MYD88</i>/<i>CXCR4</i> mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay. [PDF]

Hemasphere
Thanou E, Kollias I, Kalafati E, Vlachos C, Mavrianou-Koutsoukou N, Theologi O, Sakkou M, Liacos C, Taouxi K, Papadimou A, Chrisostomidou K, Papadopoulos A, Gavriatopoulou M, Terpos E, Lianidou E, Dimopoulos MA, Kastritis E, Markou A, Bagratuni T.   +18 more
europepmc   +1 more source